Immunodeficiency Common Variable |
47.5% |
Alpha-1 Anti-trypsin Deficiency |
7.8% |
Hypogammaglobulinaemia |
6.4% |
Plasma Cell Myeloma |
5.7% |
Hereditary Angioedema |
4.3% |
Osteoporosis |
2.8% |
Product Used For Unknown Indication |
2.8% |
Central Nervous System Lymphoma |
2.1% |
Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
2.1% |
Immunodeficiency |
2.1% |
Osteopenia |
2.1% |
Primary Immunodeficiency Syndrome |
2.1% |
Stem Cell Transplant |
2.1% |
Acute Lymphocytic Leukaemia |
1.4% |
Congenital Hypogammaglobulinaemia |
1.4% |
Deep Vein Thrombosis |
1.4% |
Osteosarcoma |
1.4% |
Prostate Cancer Metastatic |
1.4% |
Secondary Immunodeficiency |
1.4% |
Type 2 Diabetes Mellitus |
1.4% |